Analysts were unfazed by the news that Takeda will cease development of soticlestat after Phase III failures, while ...
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
Richard Redett III, M.D., has been named physician-in-chief for Johns Hopkins Medicine (JHM) and vice dean for clinical ...
Direct-to-consumer advertising can be a controversial topic in the pharma industry. While the US isn’t the only other country ...
The Lancaster County Sheriff's Office said a traffic stop on the interstate led to over $840,000 worth of prescription drugs.
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
While the former Biden administration showcased the Inflation Reduction Act as a key victory in the fight over high drug ...
A NEW SET OF TARIFFS BY THE TRUMP ADMINISTRATION WILL TAKE EFFECT, AND THEY COULD DRAMATICALLY CHANGE THE WAY YOU GET ...
The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...
Baltimore-based Johns Hopkins Medicine has appointed Richard Redett, MD, a pediatric plastic surgeon, as physician-in-chief. He will also serve as vice dean for clinical affairs at Johns Hopkins ...